Why is Zydus Lifesciences Ltd ?
- Healthy long term growth as Net Sales has grown by an annual rate of 15.02% and Operating profit at 17.74%
- Company has a low Debt to Equity ratio (avg) at 0.10 times
- The company has been able to generate a Return on Equity (avg) of 17.09% signifying high profitability per unit of shareholders funds
- PAT(Q) At Rs 924.54 cr has Fallen at -28.0%
- OPERATING CF(Y) Lowest at Rs 2,116.60 Cr
- ROCE(HY) Lowest at 16.13%
- The technical trend has improved from Mildly Bullish on 17-Nov-26
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 28.83%, its profits have fallen by -10.1%
How much should you hold?
- Overall Portfolio exposure to Zydus Lifesci. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zydus Lifesci. for you?
Low Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 6.80 times
At Rs 7,909.60 cr has Grown at 29.17%
At Rs 924.54 cr has Fallen at -28.0%
Lowest at Rs 2,116.60 Cr
Lowest at 16.13%
Highest at 0.50 times
Lowest at 10.13 times
Lowest at 2.00%
Highest at Rs 187.00 cr
Lowest at 23.95%
Lowest at Rs 1,130.50 cr.
Lowest at Rs 9.27
Here's what is working for Zydus Lifesci.
Net Sales (Rs Cr)
Debtors Turnover Ratio
Here's what is not working for Zydus Lifesci.
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Profit to Interest
Debt-Equity Ratio
Operating Cash Flows (Rs Cr)
Interest Paid (Rs cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
EPS (Rs)
DPR (%)